Bereket Alemayehu, Clinical & Training Unit Charon Gwynn, SI Unit

1. ICAP-NY DATA DISSEMINATION WEBINAR Laboratory Program and Facility Characteristics Tracking System: Round One Findings Bereket Alemayehu, Clinical & Training Unit Charon Gwynn, SI Unit

2. Please fill out webinar series survey!!!! http://www.surveymonkey.com/s/WG5JTTG

3. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

4. ICAP’s Laboratory Portfolio ALGERIA LIBYA EGYPT MAURITANIA MALI NIGER SENEGAL CHAD SUDAN BURKINA GUINEA BENIN NIGERIA ETHIOPIA COTE CENTRAL GHANA AFRICAN D’IVOIRE REPUBLIC CAMEROON Kazakhstan UGANDA DEMOCRATIC KENYA REPUBLIC THE OF THE CONGO GABON Uzbekistan RWANDA TANZANIA Kyrgyzstan Turkmenistan Tajikistan ANGOLA ZAMBIA MOZAMBIQUE ZIMBABWE NAMIBIA BOTSWANA SWAZILAND LESOTHO SOUTH AFRICA

5. Laboratory Portfolio…..Organogram

6. Laboratory Portfolio …. Program focus areas

7. Laboratory Portfolio ….. Integration of support

8. Laboratory PFaCTS • Laboratory survey that targets all labs across the tiered levels • Provides information on the scope, diversity, and comprehensiveness of laboratories • Qualitative/quantitative information - implementation of lab quality essentials(QEs) • infrastructure and equipment - human resources • quality assurance activities - Facility safety • Supply chain management

9. Rationale for Laboratory PFaCTS • Specific facility laboratory: • Laboratory’s capacity and progress toward accreditation • Gap analysis and laboratory specific improvement plan • ICAP national laboratory program: • Aggregate information to assess capacity and identify major gaps in implementing QMS across supported labs • Lab support prioritization and strategy • Program planning and implementation of improvement plans

10. PEPFAR Definition of Clinical Laboratory

11. Implementation

12. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

13. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

14. Proportion of ICAP supported laboratories participating in Laboratory PFaCTS by country

15. ICAP supported laboratories by facility type and country(n=521)

16. Type of support provided by ICAP (n=521)

17. Type of HIV-related tests performed (n=521)

18. Availability of HIV related tests by facility type

19. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

20. Location of ICAP supported equipment (n=378)

21. Equipment used for HIV and non-HIV programs

22. Inventory systems used for HIV and non-HIV programs

23. Requisition forms used for HIV and non-HIV programs

24. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

25. Quality Assurance/Quality Control (QA/QC) for key HIV-related tests

26. QA/QC frequency for HIV Rapid test (n=498)

27. QA/QC frequency for CD4 cell count test (n=159)

28. QA/QC frequency of ALT test (n=247)

29. QA/QC frequency of creatinine test (n=247)

30. Availability of standard operation procedures for HIV related testing

31. Rejection criteria for HIV related test forms and samples by country

32. Use of sample validation systems by country

33. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

34. Staff receiving training for HIV related tests

35. Staff receiving training for HIV related tests by country

36. Staff receiving key laboratory skills training (n=520)

37. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

38. Tracking of specimens and test results by country

39. Approaches to transfer test resultsto patient clinical records by country

40. Power outage frequency (n=520)

41. Backup generator availability by power outage frequency

42. laboratories having at least monthly power outages by country

43. Backup generator availability among laboratories having power outage at leastmonthly by country

44. Average number of supply shortages in year by country

45. Supply shortages by key commodity and frequency (n=519)

46. Outline • ICAP’s Laboratory Portfolio • Rationale for Laboratory PFaCTS • Laboratory PFaCTS Implementation • Findings • General Information • Health System Strengthening • Quality Assurance • Human Resources & Training • Infrastructure & Supply Management • Biosafety • Summary • Implications

47. Availability of biosafety equipment (n=521)

48. Availability of key biosafety equipment by country

49. Hazardous waste disposal methods by country

50. Hazardous waste incineration method by country